Direct vs. indirect modulation of complex in vitro human retroviral infections by morphine.
Nyland
S B
SB
Dept of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa 33612, USA.
Specter
S
S
Ugen
K E
KE
D002460:Cell Line; D015683:Gene Products, gag / Q000378:metabolism; D016655:HIV Core Protein p24 / Q000378:metabolism; D015658:HIV Infections / Q000209:etiology*; D054303:HIV Reverse Transcriptase / Q000378:metabolism; D015497:HIV-1 / Q000187:drug effects / Q000472:pathogenicity; D015490:HTLV-I Infections / Q000209:etiology*; D015368:Human T-lymphotropic virus 1 / Q000187:drug effects / Q000472:pathogenicity; D006801:Humans; D066298:In Vitro Techniques; D009020:Morphine / Q000633:toxicity*; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D015682:Retroviridae Proteins, Oncogenic / Q000378:metabolism; D015819:Substance Abuse, Intravenous / Q000150:complications; D015163:Superinfection / Q000209:etiology; D054301:gag Gene Products, Human Immunodeficiency Virus
D015683:Gene Products, gag; D016655:HIV Core Protein p24; D015682:Retroviridae Proteins, Oncogenic; D054301:gag Gene Products, Human Immunodeficiency Virus; C060955:p19 protein, Human T-lymphotropic virus 1; D009020:Morphine; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase